| Symbol | DCPXF |
|---|---|
| Name | DANCANN PHARMA A/S |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | 6823 Denmark Rugvænget 5 |
| Telephone | +45 6916 0393 |
| Fax | — |
| — | |
| Website | http://www.dancann.com/ |
| Incorporation | DK |
| Incorporated On | 2018 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Deloitte LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Spotlight Stock Market |
| CIK | — |
| Description | DanCann Pharma A/S (SS: DANCAN) was founded in 2018 and is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a vertically integrated, licensed production and distribution Company based in Denmark. The Company focuses on discovering, developing, manufacturing, and commercializing new therapeutic cannabinoids in a wide range of disease areas. Additional info from OTC: |
No news found.